Pentixapharm Holding AG has received encouraging feedback from the U.S. Food and Drug Administration (FDA) regarding its planned Phase 3 PANDA study. The formal written minutes...
The death of Hannah Goetz on July 16, 2023, has ignited serious concerns regarding the efficacy of generic drugs approved by the Food and Drug Administration...
The FDA’s policies regarding generic drugs are under scrutiny following the tragic case of Hannah Goetz, a 21-year-old lung transplant recipient whose health deteriorated after switching...
A groundbreaking health device has emerged that promises to transform home health monitoring. The newly released BeamO thermometer, developed by health technology company Withings, received FDA...
The US Food and Drug Administration (FDA) has made significant strides in the treatment of hormonal disorders throughout 2025. While the year lacked groundbreaking research breakthroughs,...
The field of psychiatry experienced significant advancements in 2025, marked by multiple approvals from the US Food & Drug Administration (FDA) aimed at improving treatment options...
Multiple chocolate and cookie products are being recalled across several states due to the presence of undeclared allergens. The recalls, announced on December 23, 2023, by...
A significant breakthrough in the treatment of a severe complication from stem cell transplants has occurred with the FDA’s approval of the first therapy specifically designed...
Researchers from Washington University School of Medicine in St. Louis have made significant strides in the treatment of amyotrophic lateral sclerosis (ALS), a debilitating neurological disease....
Cytokinetics has achieved a significant milestone with the approval of its first drug in the United States. On October 27, 2023, the U.S. Food and Drug...
